Evidence map›Paper›PMID 39588776›Full record

ArticlePain2025

The local molecular signature of human peripheral neuropathic pain.

Oliver P Sandy-Hindmarch, Pao-Sheng Chang, Paulina S Scheuren, Iara De Schoenmacker, Michèle Hubli, Constantinos Loizou, Stephan Wirth, Devendra Mahadevan, Akira Wiberg, Dominic Furniss and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Peripheral nerve injury reduces macrophage efferocytosis to facilitate neuropathic pain.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Oliver P Sandy-HindmarchNuffield Department of Clinical Neuroscience, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Pao-Sheng ChangNuffield Department of Clinical Neuroscience, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Paulina S ScheurenSpinal Cord Injury Center, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
Iara De SchoenmackerSpinal Cord Injury Center, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
Michèle HubliSpinal Cord Injury Center, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
Constantinos LoizouOxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Stephan WirthBalgrist University Hospital, University of Zurich, Zurich, Switzerland.
Devendra MahadevanRoyal Berkshire NHS Foundation Trust, Reading, United Kingdom.
Akira WibergNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
Dominic FurnissNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
Margarita CalvoDepartment of Physiology, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
David L H BennettNuffield Department of Clinical Neuroscience, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Franziska DenkWolfson Sensory, Pain and Regeneration Centre (SPaRC), King's College London, Guy's Campus, London, United Kingdom.
Georgios BaskozosNuffield Department of Clinical Neuroscience, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Annina B SchmidNuffield Department of Clinical Neuroscience, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-7759-0211

Funding

Clinical Research Priority Program (CRPP) Pain from the University of Zurich NAInternational Foundation for Research in Paraplegia P198FMichael Smith Health Research BC RT-2023-3173Ono Pharmaceutical rising star awardSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung P500PB_214416Wellcome TrustWellcome Trust 222101/Z/20/Z
6 · The paper itself

Abstract

abstractFocal nerve injuries are often associated with neuropathic pain. Preclinical research suggests altered neuroimmune signalling underlies such neuropathic pain; however, its cause remains poorly understood in humans. In this multicentre cohort study, we describe the local cellular and molecular signature of neuropathic pain at the lesion site, using Morton's neuroma as a human model system of neuropathic pain (n = 22; 18 women) compared with nerves from participants without nerve injury (n = 11; 4 women). Immunofluorescent staining revealed demyelination and chronic infiltration of immune cells in Morton's neuroma. RNA bulk sequencing identified 3349 differentially expressed genes between Morton's neuroma and controls. Gene ontology enrichment analysis and weighted gene co-expression network analyses revealed modules specific for host defence and neurogenesis. Deconvolution analysis confirmed higher densities of macrophages and B cells in Morton's neuroma than control samples. Modules associated with defence response, neurogenesis, and muscle system development as well as macrophage cell populations identified by deconvolution correlated with patients' paroxysmal or evoked pain. Of note, we identified a consistently differentially expressed gene signature ( MARCO, CD163, STAB1 ) , indicating the presence of a specific M(GC) subset of macrophages. MARCO gene expression correlated with paroxysmal pain. Targeted immunofluorescent analyses confirmed higher densities of intraneural CD163 + MARCO + macrophage subsets in Morton's neuroma. Our findings provide detailed insight into the local molecular signature in the context of human focal nerve injury. There is clear evidence for an ongoing role of the immune system in chronic peripheral neuropathic pain in humans, with macrophages and specifically the M(GC) MARCO + subset implicated.

Indexed as

NeuralgiaNeuromaAdultAgedAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenCohort StudiesFemaleHumansMacrophagesMaleMiddle AgedReceptors, Cell SurfaceAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenReceptors, Cell SurfaceImmune systemInflammationLigand-receptor analysisMacrophagesMorton's neuromaNeuroinflammationNeuropathic painPeripheral nerve injuryRNA sequencing

Identifiers

PMID39588776
PMCPMC12004989

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.